← All trials
NCT04623242
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2012
- Primary completion
- Nov 22, 2019
- Completion date
- Mar 6, 2020
- First posted
- Nov 10, 2020
- Last posted
- Nov 23, 2020
- Enrollment
- 194
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Washington University in St. LouisLead sponsor
- RocheCollaborator
- Eli LillyCollaborator
- Accelerating Medicines PartnershipCollaborator
- Washington University in St. LouisStudy director
- Avid RadiopharmaceuticalsCollaborator
- National Institute on Aging (NIA)Collaborator
- Alzheimer's AssociationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.